2-acetylaminofluorene has been researched along with Hypothyroidism in 1 studies
2-Acetylaminofluorene: A hepatic carcinogen whose mechanism of activation involves N-hydroxylation to the aryl hydroxamic acid followed by enzymatic sulfonation to sulfoxyfluorenylacetamide. It is used to study the carcinogenicity and mutagenicity of aromatic amines.
Hypothyroidism: A syndrome that results from abnormally low secretion of THYROID HORMONES from the THYROID GLAND, leading to a decrease in BASAL METABOLIC RATE. In its most severe form, there is accumulation of MUCOPOLYSACCHARIDES in the SKIN and EDEMA, known as MYXEDEMA. It may be primary or secondary due to other pituitary disease, or hypothalamic dysfunction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CANTAROW, A | 1 |
| WILLIAMS, TL | 1 |
| MELNICK, I | 1 |
| PASCHKIS, KE | 1 |
1 other study available for 2-acetylaminofluorene and Hypothyroidism
| Article | Year |
|---|---|
Influence of acetylaminofluorene, growth hormone, testosterone, and hypothyroidism on incorporation of uracil-2-C14 in liver RNA in the rat.
Topics: 2-Acetylaminofluorene; Animals; Fluorenes; Growth Hormone; Hypothyroidism; Liver; Rats; RNA; Testost | 1958 |